Drug Research
KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus
KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing agreement for the research, development, and commercialization of VET2-L2, an intravenously administered oncolytic virus for Immuno-Oncology, as well as a research collaboration to generate...
Drug Research
Catalent to Invest $10 Million to Expand High Potency Containment Capabilities for Micronization
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $10 million in isolator capabilities at its sites in Malvern,...
Drug Research
Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab for COVID-19
Eli Lilly and Company and UnitedHealth Group announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.
Bamlanivimab recently received EUA by the U.S. FDA for the treatment of mild to moderate COVID-19 patients...
Drug Research
Rush For A COVID Vaccine- Is It Science Or Politics…?
COVID-19 vaccine usage announcement by the UK has brought us to the brink where other countries too might jump on the bandwagon. Is it safe or are we rushing into things? We only hope that science triumphs over politics.
Are...
Drug Research
Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate
KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and oncology, announce...
Drug Research
ViGeneron and WuXi AppTec Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy...
Drug Research
UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out
In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizer’s coronavirus vaccine. This move may bring a lot of intensity to other countries and their respective regulators too....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















